RSV season ramps up as government examines whether to expand free vaccine access
So far this year, the National Disease Surveillance System (NDSS) has recorded more than 49,000 cases.
More than half of those cases have occurred in New South Wales, but all states and territories have experienced a rise in RSV, or respiratory syncytial virus, infections.
The RSV season typically occurs from May to September.
Since it became a notifiable disease in 2021, a record number of 175,914 RSV cases were recorded by the NDSS in 2024, the highest on record.
Pregnant women and some babies can access an RSV vaccine for free through Medicare or state-based programs, but other groups, including older Australians will have to pay. And the cost can be steep.
Here's what you need to know about getting vaccinated.
RSV is a highly contagious virus that is spread through droplets.
You're at risk of contracting RSV when an infected person talks, coughs or sneezes near you, where the virus can enter your body through your eyes, mouth or nose.
It can also be contracted when you touch a contaminated surface and don't wash your hands before touching your face.
Usually, the first symptoms are:
These symptoms tend to clear up on their own within a couple of weeks for adults who are in otherwise good health.
However, RSV can be serious for infants, young children, the elderly, and people with chronic health conditions as it may lead to complications such as pneumonia, which can be life threatening.
Yes, and the Australian Immunisation Handbook, put out by the Australian government, recommends RSV vaccines for certain population groups, including:
Only pregnant women who are enrolled or eligible for Medicare can currently access the Abrysvo RSV vaccine for free under the federal government's National Immunisation Program.
The government's $174.5 million investment kicked off in February 3 this year.
Eligible infants and young children can also receive an RSV immunisation called Nirsevimab, also known as Beyfortus, for free through state and territory-funded programs, without the need for Medicare.
The vaccine works by directly providing antibodies to the infant, providing immediate protection against RSV for up to six months.
While the vaccines for eligible children are free, some providers may charge a service fee for the procedure.
To find out more about child immunisations, visit the health website for your state or territory.
Everyone else needs to purchase the vaccine, which can come at a steep cost.
One Australian pharmacy chain advertises a dose of the Abrysvo RSV vaccine at more than $330.
The high price of the vaccine itself, in addition to the cost of seeing a GP to get a prescription and have the injection administered if required, can be cost prohibitive.
The Royal Australian College of General Practitioners (RACGP) is advocating for free access to RSV vaccines for everyone recommended by the Australian Immunisation Handbook.
Dr Ramya Raman, the RACGP vice-president, said the vaccine had already been a "gamechanger" for the community.
Case numbers have fallen since RSV vaccines and the monoclonal antibody were introduced, with 56,303 cases recorded from January to April 2024 compared with 40,380 for the same time period this year, according to data from the NDSS.
Dr Raman said the RSV vaccine's proven success at reducing the number of infections and hospitalisations means "we've got to look at this as an opportunity and call for the expansion of it".
"Given how common how this condition is and the effectiveness of the vaccinations it would be wonderful to see this within the schedule."
This comes in light of the 2024 Annual Australian Respiratory Surveillance Report from the interim Australian Centre for Disease Control, which states that older Australians are more likely to die from RSV than younger Australians.
The Pharmaceutical Benefits Advisory Committee (PBAC) is in charge of recommending what vaccines be made available for free in Australia.
In November last year, the PBAC recommended the free provision of the Abrysvo RSV vaccine be expanded to include all adults over 75 and Aboriginal and Torres Strait Islander peoples over 60.
But this change to the National Immunisation Program (NIP) has yet to occur.
A spokesperson for the Department of Health, Disability and Ageing said: "Other steps need to be completed before a vaccine can be given final approval for NIP listing."
"These include negotiations with the relevant pharmaceutical company; finalisation of conditions for listing; quality and availability checks; and final consideration by the government," the spokesperson said.
They said the PBAC advised the department that "economic inputs should be revised for Abrysvo to become cost effective before it can be accepted for NIP listing".
And while they said the government's considerations and decisions "cannot be pre-empted", they did confirm the department "is currently reviewing the PBAC outcome and is actively working with the vaccine sponsor on next steps".
Health authorities recommend maintaining good hygiene practices to limit the spread of the virus.
The government-funded service Healthdirect advises people to take the following steps:
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Australian
an hour ago
- The Australian
Historic NSW health worker wage deal: the new benefits
A new two-year wage agreement is set to deliver pay increases and improved conditions for tens of thousands of NSW health workers. The NSW government and the Health Services Union NSW (HSU NSW) have finalised the landmark two-year salary agreement delivering significant pay rises and better conditions for more than 50,000 public health workers across the state. The deal provides an 8.5 per cent pay increase over two years, exceeding the government's 3 per cent wage policy. Workers will receive a 4 per cent pay rise in the first year, followed by a further 4 per cent increase plus an additional 0.5 per cent superannuation contribution in the second year. The new agreement will give health workers an 8.5 per cent pay increase in two years. Picture: Christian Gilles / NewsWire It covers a wide range of NSW Health staff including allied health workers, hospital cleaners, scientists, security officers, patient transport officers, pharmacy assistants, linen workers, and wardspeople. HSU NSW secretary Gerard Hayes said the agreement was a 'big stride towards wage justice' for those who kept hospitals clean, safe, and patient-focused. 'This historic agreement recognises the indispensable work of pharmacy assistants, security officers, linen workers, cleaners and wardspeople,' Mr Hayes said. 'These workers are often overlooked, yet without them, our hospitals would collapse. 'Over the four years to June 2027, a hospital assistant will see their pay jump by more than $10,000, from around $52,000 to over $62,000. 'A wardsperson's annual salary will be $10,400 higher by 2026-27, while security officers will pocket an additional $10,500 per year. That's real money that makes a real difference to working families.' HSU NSW Secretary Gerard Hayes said the agreement was a 'big stride towards wage justice'. Picture: NewsWire / Jeremy Piper The agreement also supports allied health professionals such as occupational therapists, physiotherapists, social workers, dietitians, and speech pathologists through a formal work value case process with the Industrial Relations Commission. Mr Hayes said these workers had increasingly taken on more complex responsibilities, honed new skills, and broadened their scope of practice, yet their compensation had not kept pace. 'The work value case provisions give them the platform they deserve to have their true worth recognised and compensated,' Mr Hayes said. Additional workplace benefits include earlier payment of higher-grade duties after three days instead of five, rest periods between rostered shifts increased to 10 hours from eight hours, and a requirement for four weeks' notice for roster changes, up from the previous two weeks. Health Minister Ryan Park said they were 'rebuilding a supported and capable workforce'. Picture: NewsWire / Nikki Short The agreement also builds on HSU NSW's successful campaign for full salary packaging benefits, providing thousands of dollars in additional value to typical hospital workers. Mr Hayes said the deal provided members with certainty and security while sustaining their drive for fairer pay. 'It shows what can be achieved when workers stand together and when government recognises the essential contribution of healthcare workers,' Mr Hayes said. NSW Treasurer Daniel Mookhey said the offer was a major step in repairing the state's healthcare system. 'This offer to increase wages and deliver benefits to more than 50,000 health workers across NSW is a major next step in repairing our state's healthcare,' Mr Mookhey said. A landmark wage deal has been reached for more than 50,000 NSW health workers. NewsWire / Nikki Short 'These allied health workers, hospital cleaners, scientists, security officers, patient transport officers and others play a crucial role in giving the people of NSW the care they expect.' Health Minister Ryan Park said they were 'rebuilding a supported and capable workforce'. 'We abolished the wages cap and established a new bargaining framework,' Mr Park said. 'We are working to fix recruitment and retention. 'More health staff, lower wait times, better health outcomes – it's as simple as that.' Minister for Industrial Relations Sophie Cotsis said the multi-year agreement was the first of its kind in more than a decade for these essential workers. '(It) represents a significant step forward in recognising their vital contribution and ensuring fairer pay and conditions into the future,' Ms Cotsis said. Andrew Hedgman Reporter Andrew Hedgman is a journalist for NCA Newswire. Andrew Hedgman
ABC News
4 hours ago
- ABC News
'A long day coming': Canberra's new hydrotherapy pool ready to open in Tuggeranong after five-year wait
Osteoarthritis and psoriatic arthritis leave Patricia Clark in pain "24-hours a day, every day". The 74-year-old lives by herself and is dependent on a walker to get around. "I've got pain in my lower back and it's causing weakness in my legs, so it's hard to stay upright," she said. "I have trouble standing at the sink to prepare meals or to do anything standing up is difficult." One of her main sources of pain relief is hydrotherapy — so she is relieved that, after a five-year wait, a new hydrotherapy pool has finally been finished in Canberra's south. "The warmth of the water immediately relaxes your body as soon as you go in, you feel this immediate freedom," she said. "Plus the water supports your body ... to be able to walk without a walker. The $8.5 million facility, at the Lakeside Leisure Centre in Greenway, was a 2020 ACT government election promise to replace the Canberra Hospital hydrotherapy pool that closed the same year. Ms Clark was among the pool users who fought to stop the closure of the Canberra Hospital pool, and has since had to use a "cold" learn-to-swim pool for her therapy. "As the years have gone on I've lost patience ... thinking it would never happen," she said. While the pool's opening is a welcome milestone to reach, Ms Clark said she is still "a bit apprehensive" about the availability of sessions in the pool. "We don't know how much opportunity we will have to use it," she said. It's a concern shared by Arthritis ACT, which has been running up to 50 hydrotherapy sessions at the University of Canberra Hospital pool each week. With each session only able to take 12 people, all of their sessions have been full. "To be honest, it's been a long day coming. There's just so many more people [in need]," Arthritis ACT exercise physiologist Sophie Bullock said. Tuggeranong Community Council president Glenys Patulny suspects the new pool will be "heavily in demand". "There are about 90,000 people in Tuggeranong and this will actually service a lot of Woden and Weston Creek as well," she said. While the new pool is designed to "complement" the University of Canberra Hospital's hydrotherapy pool, Ms Bullock said there were still very few accessible and affordable pools in Canberra. "Managing a chronic condition is not a cheap thing to do and with a lot of private pools … you may not have $25 per [session]," she said. "When you're living on a pension is very hard to try and manage." Health Minister Rachel Stephen-Smith acknowledged the "continuing demand for hydrotherapy across our community". "We will continue listening to the community's feedback about the need for more services," she said. The new Tuggeranong hydrotherapy pool features underfloor heating and a water temperature of 33 to 34 degrees Celsius, and is designed to support people with chronic conditions such as arthritis and cancer, and people recovering from injury. "Most people with chronic pain now understand that you can't just keep popping a pill, there is no golden pill to get rid of chronic pain," Arthritis ACT CEO Rebecca Davey said. Ms Davey said hydrotherapy pools could "almost trick the central nervous system" and bring relief for those suffering chronic pain and movement conditions. "So that when you're in water that's about 34 degrees warm, it tells your brain that the pain is not so bad and then people are able to get along," she said. "Not only are they exercising and building their bodies up again, but they're also getting pain relief and that pain relief can last up to 48 hours after a session. The new Tuggeranong hydrotherapy pool is due to open to the public on August 25.
The Australian
6 hours ago
- The Australian
Health Kick Podcast: Alterity Therapeutics
Stockhead's health and biotech expert Tim Boreham is back in the studio for another instalment of the Health Kick Podcast. In this episode, Tim speaks with Alterity Therapeutics (ASX:ATH) CEO Dr David Stamler, who sheds light on a little-known but devastating neurological condition, multiple system atrophy (MSA). MSA may not have the public awareness of Parkinson's or ALS, but it's every bit as serious, and Alterity is aiming to change that. With no approved treatments currently available, MSA represents a major unmet clinical need. Alterity's lead candidate, ATH434, is designed to address a unique biological mechanism involving iron imbalance in the brain. Tune in to hear how ATH434 is showing promise in slowing disease progression, the science behind iron maldistribution in neurodegenerative disease, and how Dr Stamler's decades of FDA drug development experience is helping drive this program forward. This podcast was developed in collaboration with Alterity Therapeutics, a Stockhead advertiser at the time of publishing. The interviews and discussions in this podcast are opinions only and not financial or investment advice. Listeners should obtain independent advice based on their own circumstances before making any financial decisions.
